ABVC BioPharma News - ABVC

Company Name	Stock Ticker Symbol	Market	Type
ABVC BioPharma Inc	ABVC	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.14	-8.81%	1.45	18:32:47

Open Price	Low Price	High Price	Close Price	Prev Close
1.4901	1.40	1.57	1.42	1.59

more quote information »

Recent News

Date	Time	Source	Heading
4/18/2024	09:25	GLOBE	AiBtl BioPharma Inc. Acquired TT Life Company, Valued at..
4/17/2024	09:00	GLOBE	ABVC BioPharma Executes a Global Licensing Definitive..
4/10/2024	08:30	GLOBE	ABVC BioPharma Executes a Global Licensing Term Sheet for..
3/26/2024	08:30	GLOBE	ABVC BioPharma Entered into a Global Licensing Deal of..
3/21/2024	08:30	GLOBE	AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging..
3/19/2024	08:30	GLOBE	ABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO..
3/14/2024	09:30	GLOBE	ABVC BioPharma Reports Annual 2023 Financials and Provides..
2/29/2024	16:32	EDGAR2	Form 8-K/A - Current report: [Amend]
2/29/2024	16:31	EDGAR2	Form 8-K/A - Current report: [Amend]
2/27/2024	08:30	GLOBE	ABVC's New Horizon for Oncology and Hematology Aims at..
2/16/2024	17:04	EDGAR2	Form S-1/A - General form for registration of securities..
2/15/2024	08:30	GLOBE	ABVC BioPharma Executes a Definitive Agreement to Receive..
2/13/2024	19:59	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/12/2024	08:30	GLOBE	ABVC BioPharma Receives Australian Patent, Valid Until 2040,..
2/09/2024	17:04	EDGAR2	Form S-1/A - General form for registration of securities..
2/08/2024	09:30	EDGAR2	Form 8-K - Current report
2/08/2024	09:17	GLOBE	ABVC Acquires $2.96 Million Worth of Land in Asia with..
1/17/2024	17:01	EDGAR2	Form 8-K/A - Current report: [Amend]
1/17/2024	17:00	EDGAR2	Form 8-K - Current report
1/17/2024	16:30	EDGAR2	Form 8-K - Current report
1/12/2024	17:01	EDGAR2	Form S-1 - General form for registration of securities under..
1/03/2024	07:24	GLOBE	ABVC BioPharma and its Subsidiary Receive $460M From AiBtl..
12/07/2023	08:30	GLOBE	ABVC BioPharma Announces Completion of Subject Treatment for..
12/05/2023	08:30	GLOBE	ABVC BioPharma Shares Insights from Dr. Scott Irwin of..
11/21/2023	08:30	GLOBE	ABVC BioPharma Receives U.S. Patent for ADHD Treatment, a..
11/20/2023	08:30	EDGAR2	Form 8-K - Current report
11/17/2023	17:00	EDGAR2	Form 424B4 - Prospectus [Rule 424(b)(4)]
11/17/2023	17:00	EDGAR2	Form 424B4 - Prospectus [Rule 424(b)(4)]
11/16/2023	10:05	GLOBE	ABVC BioPharma Enters Definitive Agreement with Licensing..
11/16/2023	09:20	EDGAR2	Form 8-K - Current report
11/15/2023	09:00	GLOBE	ABVC BioPharma Reports Third Quarter 2023 Financial and..
11/15/2023	08:41	EDGAR2	Form 8-K - Current report
11/15/2023	08:00	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/26/2023	08:30	GLOBE	ABVC BioPharma Entered Into a Term Sheet to License Global..
10/17/2023	08:30	GLOBE	ABVC BioPharma Announces Completion of Subject Recruitment..
10/09/2023	08:30	GLOBE	ABVC BioPharma Receives Taiwanese Patent for Its Treatment..
9/13/2023	09:01	EDGAR2	Form 8-K - Current report
9/06/2023	08:30	EDGAR2	Form 8-K/A - Current report: [Amend]
8/31/2023	08:30	EDGAR2	Form 8-K - Current report
8/23/2023	08:30	GLOBE	ABVC BioPharma Provides Updates on ADHD Phase IIb Clinical..
8/17/2023	17:00	EDGAR2	Form 424B4 - Prospectus [Rule 424(b)(4)]
8/17/2023	17:00	EDGAR2	Form 424B4 - Prospectus [Rule 424(b)(4)]
8/17/2023	09:19	GLOBE	ABVC Executes Cooperation Agreement for Strategic..
8/17/2023	08:33	EDGAR2	Form 8-K - Current report
8/14/2023	16:30	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/2023	08:30	GLOBE	ABVC BioPharma Regains Compliance With Nasdaq's Minimum Bid..
8/09/2023	17:00	EDGAR2	Form 8-K/A - Current report: [Amend]
8/07/2023	16:01	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
8/07/2023	08:30	GLOBE	ABVC Corporate Update and CEO's Letter to Shareholders
8/07/2023	08:00	EDGAR2	Form 8-K - Current report